Victor Sandor's Net Worth

$22.1 Million

Estimate Recalculated Jun 5, 2025 08:08PM EST

Who is Victor Sandor

Victor Sandor has an estimated net worth of $22.1 Million. This is based on reported shares across multiple companies, which include Prelude Therapeutics Inc, Merus N.V., ARRAY BIOPHARMA INC, Kymera Therapeutics, Inc., and ADC Therapeutics SA.

SEC CIK

Victor Sandor's CIK is 0001620368

Past Insider Trading and Trends

2018 was Victor Sandor's most active year for acquiring shares with 9 total transactions. Victor Sandor's most active month to acquire stocks was the month of May. 2019 was Victor Sandor's most active year for disposing of shares, totalling 22 transactions. Victor Sandor's most active month to dispose stocks was the month of May. 2019 saw Victor Sandor paying a total of $1,284,296.30 for 267,488 shares, this is the most they've acquired in one year. In 2019 Victor Sandor cashed out on 2,003,623 shares for a total of $17,942,524.96, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Prelude Therapeutics Inc

Investor
Updated Jun 18, 2024
Form 4
23.50K
Jun 18, 2024
23.50K
Grant
Jun 14
Form 4
23.50K
Jun 21, 2023
23.50K
Grant
Jun 16
Form 4
34.30K
Jun 22, 2022
34.30K
Grant
Jun 17
Form 4
11.21K
Jan 05, 2022
11.21K
Grant
Jan 03
Form 4
8.02K
Oct 14, 2021
8.02K
Grant
Oct 13
Form 4
23.34K
Jun 22, 2021
23.34K
Grant
Jun 18
Form 4
3.46K
Sep 28, 2020
3.46K
Grant
Sep 24
Form 3
Sep 24, 2020
Showing 8 results

Merus N.V.

Investor
Updated May 09, 2024
Form 4
8.84K
May 09, 2024
8.84K
Grant
May 07
Form 4
14.41K
Jun 12, 2023
14.41K
Grant
Jun 08
Form 4
16.60K
Jun 02, 2022
16.60K
Grant
May 31
Form 4
6.12K
Jun 02, 2021
6.12K
Grant
May 28
Form 4
8.63K
Jul 02, 2020
8.63K
Grant
Jun 30
Form 3
Jan 02, 2020
Showing 6 results

ARRAY BIOPHARMA INC

Chief Medical Officer
Updated Jul 30, 2019
Form 4
-100.00%
-1.45M
$48.00
Jul 30, 2019
Disposition
Jul 30
Form 4
-25.19%
-100.00K
$17.91
-$2.12M
Jun 06, 2019
297.04K
Sale
ScheduledJun 04
Form 4
-19.84%
-51.86K
$15.60
-$1.24M
Jun 03, 2019
209.54K
Sale
ScheduledMay 30 - Jun 03
Form 4
-24.30%
-115.55K
$15.24
-$2.78M
May 28, 2019
360.03K
Sale
ScheduledMay 23 - May 28
Form 4
-3.23%
-12.60K
$15.08
-$287.91K
May 23, 2019
376.95K
Sale
ScheduledMay 21
Form 4
-2.93%
-6.93K
$24.60
-$170.53K
Apr 03, 2019
245.51K
Options
Apr 01
Form 4
-2.66%
-6.27K
$14.05
-$88.09K
Jan 02, 2019
229.00K
Sale
ScheduledDec 27
Form 4
107.55%
327.37K
$15.97
-$165.74K
Dec 18, 2018
631.77K
Options
Dec 14 - Dec 16
Form 4
-23.54%
-115.19K
$9.93
-$1.40M
Dec 06, 2018
374.16K
Sale
ScheduledDec 03
Form 4
-4.41%
-9.69K
$15.38
-$148.94K
Sep 05, 2018
210.09K
Sale
ScheduledSep 04
Form 4
-3.41%
-7.75K
$18.50
-$143.43K
Jun 29, 2018
219.77K
Options
Jun 27
Form 4
-13.68%
-77.58K
$11.21
-$1.17M
Jun 21, 2018
489.35K
Sale
ScheduledJun 19
Form 4
-3.80%
-22.42K
$11.20
-$338.60K
Jun 15, 2018
566.92K
Sale
ScheduledJun 13
Form 4
-6.47%
-15.63K
$15.78
-$246.57K
Apr 03, 2018
225.71K
Sale
ScheduledApr 01 - Apr 03
Form 4
-20.71%
-156.02K
$10.68
-$2.10M
Mar 09, 2018
597.16K
Sale
ScheduledMar 09
Form 4
143.98%
332.44K
$9.86
$41.20K
Dec 19, 2017
563.33K
Options
Dec 16
Form 4/A
-4.12%
-7.30K
$8.94
-$65.29K
Apr 06, 2017
170.13K
Tax
Apr 01
Form 4
-2.50%
-5.02K
$8.94
-$44.90K
Apr 04, 2017
195.84K
Options
Apr 01
Form 4
315.97K
Dec 29, 2016
315.97K
Grant
Dec 27
Form 4
-15.50%
-31.12K
$3.69
$239.01K
Sep 23, 2016
169.62K
Options
Sep 22
Form 4
201.03%
216.10K
$3.00
-$7.95K
Apr 05, 2016
323.59K
Grant
Apr 01
Form 4
-13.29%
-31.16K
$5.18
$335.28K
Sep 24, 2015
203.39K
Options
Sep 22
Form 4
1,899.20%
218.75K
Apr 03, 2015
230.27K
Grant
Apr 01
Form 4
-16.64%
-5.80K
$7.96
$92.61K
Mar 04, 2015
29.08K
Options
Mar 01
Form 3
Sep 24, 2014
Showing 25 results

Kymera Therapeutics, Inc.

Investor
Updated Jun 20, 2024
Form 4
16.00K
Jun 20, 2024
16.00K
Grant
Jun 18
Form 4
12.00K
Jun 20, 2023
12.00K
Grant
Jun 15
Form 4
24.00K
Nov 03, 2022
24.00K
Grant
Nov 03
Form 3
Nov 03, 2022
Showing 4 results

ADC Therapeutics SA

Investor
Updated Jun 18, 2024
Form 4
-7.96%
-7.00K
$2.89
-$20.22K
Jun 18, 2024
80.89K
Sale
Jun 17
Form 4
83.54%
40.00K
Jun 14, 2024
87.88K
Grant
Jun 13
Form 3
Jan 02, 2024
47.88K
Showing 3 results